XEN 45 GTS
Report
- Report Number
- 3011299751-2023-00079
- Event Type
- Injury
- Date Received
- May 1, 2023
- Date of Event
- April 25, 2018
- Report Date
- May 1, 2023
- Manufacturer
- ALLERGAN (IRVINE)
- Product Code
- KYF
- UDI-DI
- 10888628032439
- PMA / PMN Number
- K161457
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MD, US
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
CONTINUED H.6. HEALTH EFFECT - IMPACT CODES: F2303, F2301. ARTICLE CITATION: LEE, IAN BS, ET AL. "SHORT-TERM OUTCOMES OF XEN 45 GEL STENT AB INTERNO VERSUS AB EXTERNO TRANSCONJUNCTIVAL APPROACHES." J GLAUCOMA. 2023 MAR 13. DOI: 10.1097/IJG.0000000000002208. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ALLERGAN IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THE EVENT IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.
HEALTHCARE PROFESSIONAL REPORTED A PATIENT WAS IMPLANTED WITH A XEN®45 GTS IN THE LEFT EYE. PATIENT WOULD HAVE A WOUND LEAKAGE ON POST OP DAY 1 THAT RESOLVED BY POST-OP WEEK 1. IT WAS NOTED ON POST OP WEEK 1, HOWEVER, THAT THE IRIS WAS PLUGGING THE XEN WITH AN IOP OF 34 AND SEVERE ENCAPSULATION. THIS REQUIRED A LASER IRIDOPLASTY. ON POST OP WEEK 2-3, PATIENT HAD AN IOP OF 20MMHG THAT REQUIRED STARTING OF 3 IOP MEDICATIONS. PATIENT ULTIMATELY WOULD HAVE AN IOP OF 51MMHG AROUND POST-OP MONTH 6-8 THAT WAS NOT CONTROLLED ON A TOTAL OF 4 IOP MEDICATIONS, REQUIRING PLACEMENT OF AN AHMED VALVE. DEVICE REMAINS IMPLANTED. THIS LITERATURE ARTICLE WAS PREVIOUSLY REPORTED UNDER MDR ID #3011299751-2023-00040. THIS MDR IS BEING SUBMITTED FOR SPECIFICALLY FOR THIS PATIENT THAT WAS ADDITIONALLY PROVIDED BY THE AUTHOR.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1275192 | XEN 45 GTS | IMPLANT, EYE VALVE | KYF | ALLERGAN (IRVINE) | 5513-001 | NI | 10888628032439 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR | Male | Required Intervention |